These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 16386606)
21. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339 [TBL] [Abstract][Full Text] [Related]
22. Use of sirolimus to facilitate steroid withdrawal from a cyclosporine regimen. Kahan BD; Podbielski J; Schoenberg L Transplant Proc; 2006 Nov; 38(9):2842-6. PubMed ID: 17112844 [TBL] [Abstract][Full Text] [Related]
23. Impact of graft volume reduction for oversized grafts after lung transplantation on outcome in recipients with end-stage restrictive pulmonary diseases. Shigemura N; Bermudez C; Hattler BG; Johnson B; Crespo M; Pilewski J; Toyoda Y J Heart Lung Transplant; 2009 Feb; 28(2):130-4. PubMed ID: 19201337 [TBL] [Abstract][Full Text] [Related]
28. Mycobacterium tuberculosis infection following renal transplantation in Taiwan. Chen CH; Lian JD; Cheng CH; Wu MJ; Lee WC; Shu KH Transpl Infect Dis; 2006 Sep; 8(3):148-56. PubMed ID: 16913973 [TBL] [Abstract][Full Text] [Related]
29. [Steroid withdrawal in renal transplant recipients]. Nakamura H; Murai M; Asano T; Takao M; Yoshizawa N; Sekiguchi S Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1033-7. PubMed ID: 2263025 [TBL] [Abstract][Full Text] [Related]
30. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome. Borro JM; Bravo C; Solé A; Usetti P; Zurbano F; Lama R; De la Torre M; Román A; Pastor A; Laporta R; Cifrián JM; Santos F Transplant Proc; 2007 Sep; 39(7):2416-9. PubMed ID: 17889206 [TBL] [Abstract][Full Text] [Related]
31. Steroid withdrawal in living donor renal transplant recipients using tacrolimus and cyclosporine: a randomized prospective study. Park JB; Kim SJ; Oh HY; Han YS; Kim DJ; Park JW; Kwon CH; Joh JW; Lee SK Transpl Int; 2006 Jun; 19(6):478-84. PubMed ID: 16771869 [TBL] [Abstract][Full Text] [Related]
36. Late corticosteroid withdrawal can be safely performed for kidney recipients with stable graft function under pathological confirmation. Harada H; Miura M; Ogawa Y; Seki T; Taniguchi A; Takenouchi T; Togashi M; Hirano T Clin Transplant; 2006; 20 Suppl 15():26-32. PubMed ID: 16848872 [TBL] [Abstract][Full Text] [Related]
38. Isolated lung transplantation; initial experience at the University Hospitals Leuven. Leuven Lung Transplant Group. Van Raemdonck D; Verleden G; Coosemans W; Michiels E; De Leyn P; Buyse B; Demedts M; Lerut T Acta Chir Belg; 1994; 94(5):245-57. PubMed ID: 7976065 [TBL] [Abstract][Full Text] [Related]
39. Different survival of long-term kidney transplant recipients treated with daily or alternate day corticosteroids. Di Padova F; Di Palo FQ; Morandi E; Elli A; Vallino F Methods Find Exp Clin Pharmacol; 1982; 4(1):43-8. PubMed ID: 7045548 [TBL] [Abstract][Full Text] [Related]
40. No occurrence of de novo HLA antibodies in patients with early corticosteroid withdrawal in a 5-year prospective randomized study. Delgado JC; Fuller A; Ozawa M; Smith L; Terasaki PI; Shihab FS; Eckels DD Transplantation; 2009 Feb; 87(4):546-8. PubMed ID: 19307792 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]